MedTrace Logo

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

NCT02940977 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2018-07-10

No results posted yet for this study

Summary

1. To elucidate the role of CTC detection in the evaluation of risk level in PCa patients, and establish a mathematic model for predicting the pathological status.
2. To explore the possible subtle change in CTC condition after radical prostatectomy.

Conditions

  • Prostatic Neoplasms
  • Prostatic Adenoma

Interventions

OTHER

Blood draws

Blood draws, from peripheral veins, each time 2 tubes, each 5 ml.

Sponsors & Collaborators

  • Shanghai Shen Kang Hospital Development Center

    collaborator OTHER

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2019-03-30
Completion
2019-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02940977 on ClinicalTrials.gov